PPT-Trends in Opioid Availability and Abuse

DEA Philadelphia Field Division Intelligence Program July 2018 UNCLASSIFIED Threats What you already know Pennsylvania is in the midst of a drug abuse and overdose epidemic Prescription opioid abuse fueled heroin abuse. Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None.      Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill.  He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship.  While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972.  For this he receive the  Meritorious Service Medal.  He has practiced adult psychiatry in Grand Junction for 28 years.  He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. . Child Welfare League of America . National Advocacy Summit. Washington, DC. April 20, 2016. Robert Morrison, Executive Director/Director of Legislative & Regulatory Affairs. National Association of State Alcohol and Drug Abuse Directors (NASADAD). Prescription opioid abuse and the resurgence of heroin. Opioid Crisis Summit Meeting. October 17, . 2017. Dr. Theodore J. Cicero, PhD. Washington University in St. Louis,. Department of Psychiatry. Email: . Prescription opioid abuse and the resurgence of heroin. Statewide Public . Health System . Meeting. July 27, . 2017. Dr. Theodore J. Cicero, PhD. Washington University in St. Louis,. Department of Psychiatry. Analgesics and Opioids. Analgesics are drugs that relieve pain without causing loss of consciousness.. Opioids are the . most effective pain relievers available.. Terminology. Opioid. . A general term defined as any drug, natural or synthetic, that . of the . Opioid Abuse Epidemic . in North . America. October 24, 2017. Richard C. Dart, MD, PhD. Executive Director, RADARS . System. Professor, University of Colorado School of Medicine. Richard.Dart@rmpdc.org. Joshua P. Cohen, PhD. Massachusetts State House. February 5, 2018. 20% of non-cancer pain patients are prescribed an . opioid. , compared to <5% in other industrialized nations. U.S. has 4% of the world’s population, yet 30% of global . Effectiveness and Value. Presentation to the Massachusetts Drug Formulary Commission. February 5, 2018. Presentation Agenda. Introduction to ICER. Comparative clinical effectiveness of abuse-deterrent formulations of opioids (ADFs). Ernest J Dole, PharmD, . PhC. , FASHP, BCPS. Clinical Pharmacist & . Asso. . Clinical Prof.. University of New Mexico Hospitals & College of Pharmacy. Albuquerque, NM. Learning Objectives. At the end of this presentation, utilizing a case of an older patient on chronic opioid therapy (COT) with the comorbidity of geriatric opioid abuse (GOA) the participant will be able to. Norma Holtz RPH. Pharmacist . The Medicine Shoppe. 217 S Main St.. Farmer City, IL 61842. Thank you for inviting me to the parent Academy. Children in crisis – what do I look for and how to help... Understand the scope of the problem. Understand dentists role in addressing the problem. Recommendations for prescribing. Strategies to . reduce opioid abuse. Gary W. Allen, DMD,MS. Vice President of Dental Services. How does legislation fit into RALI146s missionRALIwill work to educate and partner with policymakers at all levels of government in order to advance solutions that stem the tide of the opioid crisis W Joshua Blum MD. April 7, 2018. No relevant financial disclosures. Learning objectives. Utilize the latest evidence around opioid-induced hyperalgesia to mitigate negative consequences . Implement best practices around opioid rotation to manage OIH.